Look Beyond the Hype
Not All AI Is Created Equal
Discover the Unrivaled Power of ProFound AI
RSNA 2021 | South Hall Meeting Suites 214 – 216
Learn More
ProFound AI® Risk
Revolutionizing Personalized Screening
Now available for 2D and 3D mammography
Learn More
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
POWERFUL CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
Discover the Unrivaled Power of ProFound AI at RSNA 2021
Investor Webinar - Replay
Optimizing outcomes and efficiency: iCAD’s world-class solutions for the early detection and treatment of cancer
PLAY WEBINAR
Recent News
November 30, 2021
Arterys Signs Global Distribution Agreement With iCAD, Inc. to Launch Its New Breast AI SaaS Solution
November 29, 2021
iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021
November 11, 2021
iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference
November 11, 2021
iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment
November 9, 2021
iCAD Reports Financial Results for the Quarter Ended September 30, 2021
» View All News »
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.